Latest News and Press Releases

Media Release SYDNEY, AUSTRALIA, Nov. 02, 2022 (GLOBE NEWSWIRE) --  Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing novel...

San Luis Obispo, Nov. 01, 2022 (GLOBE NEWSWIRE) -- San Luis Obispo, California - Dental Marketing Guy is excited to offer guaranteed dental SEO services to businesses worldwide. With a team of...

AUSTIN, TX and DURHAM, NC, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion...

WATERTOWN, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced the opening of...

― Data Center, Gaming and Embedded segments each grew significantly year-over-year and Client segment revenue was lower than expected ― ― Cash and operating cash flow increased year-over-year ― ...

HOUSTON, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific” or the “Company”) today reported its financial results for the quarter ended September 30, 2022. ...

Consolidated revenues were $745.3 million, down 1.8%, and up 4.8% on an organic constant currency (OCC) basis for the third quarter of 2022. The decline in our consolidated revenue was primarily due...

MINNEAPOLIS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative,...

First Quarter Highlights Include:Bookings of $266.9M yielding book-to-bill of 1.17Record backlog of $1.08 billionContinues to be well positioned for strong FY23 ANDOVER, Mass., Nov. 01, 2022 (GLOBE...

Reported positive data from EPIPHAST II trial comparing AQST-109 (epinephrine sublingual film) to EpiPen® 0.3mg (single dose) and AQST-109 to epi 0.3mg IM injection (repeat dose)Scheduled End-of-Phase...